Vitality Watch

Dossier pubmed review 01-sep-2026
Narrative review or expert overview without new data

Reframing obesity in aging people with HIV: sarcopenic obesity, muscle quality, and frailty.

Key claim: Obesity in aging populations should be reframed around sarcopenic obesity, myosteatosis, and frailty rather than weight alone, prioritizing resistance training to prevent functional decline and lean tissue loss.

Abstract

PURPOSE OF REVIEW: As people with HIV (PWH) age, obesity is increasingly prevalent, yet body weight alone inadequately captures the functional and metabolic consequences of adverse body composition remodeling. This review examines emerging evidence supporting a shift from weight-centric approaches toward a framework centered on sarcopenic obesity, muscle quality, and frailty in aging PWH. RECENT FINDINGS: Weight gain in the contemporary antiretroviral therapy era often reflects increased visceral and ectopic adiposity. Sarcopenic obesity is a clinically relevant phenotype characterized by the coexistence of excess adiposity and impaired muscle mass or function, with important implications for healthy aging. Emerging evidence highlights myosteatosis and impaired muscle quality as potential mechanistic links between adiposity and functional decline. Exercise-based interventions, particularly those incorporating resistance training, demonstrate promise for preserving physical function, reducing frailty, and improving body composition. In contrast, pharmacologic weight loss may raise concerns regarding lean tissue preservation if implemented without a concurrent focus on muscle health. SUMMARY: Obesity in aging PWH should be reframed as a body composition and functional health problem rather than simply excess body weight. Clinical and research priorities should emphasize early identification of vulnerability, preservation of muscle health, and interventions that support long-term physical resilience and independence.

Why this matters

Obesity in aging populations should be reframed around sarcopenic obesity, myosteatosis, and frailty rather than weight alone, prioritizing resistance training to prevent functional decline and lean tissue loss.

Source

Link

Briefing card

Reframing obesity in aging people with HIV: sarcopenic obesity, muscle quality, and frailty.
Stage: review · pubmed · 01-sep-2026

Obesity in aging populations should be reframed around sarcopenic obesity, myosteatosis, and frailty rather than weight alone, prioritizing resistance training to prevent functional decline and lean tissue loss.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1097/COH.0000000000001067

build build 880 · 2bcef25 · 2026-11-18